Author: Camps, Jordi; Castañé, Helena; RodrÃguez-Tomà s, Elisabet; Baiges-Gaya, Gerard; Hernández-Aguilera, Anna; Arenas, Meritxell; Iftimie, Simona; Joven, Jorge
Title: On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update Cord-id: u4hxzuc2 Document date: 2021_7_1
ID: u4hxzuc2
Snippet: Infectious and many non-infectious diseases share common molecular mechanisms. Among them, oxidative stress and the subsequent inflammatory reaction are of particular note. Metabolic disorders induced by external agents, be they bacterial or viral pathogens, excessive calorie intake, poor-quality nutrients, or environmental factors produce an imbalance between the production of free radicals and endogenous antioxidant systems; the consequence being the oxidation of lipids, proteins, and nucleic
Document: Infectious and many non-infectious diseases share common molecular mechanisms. Among them, oxidative stress and the subsequent inflammatory reaction are of particular note. Metabolic disorders induced by external agents, be they bacterial or viral pathogens, excessive calorie intake, poor-quality nutrients, or environmental factors produce an imbalance between the production of free radicals and endogenous antioxidant systems; the consequence being the oxidation of lipids, proteins, and nucleic acids. Oxidation and inflammation are closely related, and whether oxidative stress and inflammation represent the causes or consequences of cellular pathology, both produce metabolic alterations that influence the pathogenesis of the disease. In this review, we highlight two key molecules in the regulation of these processes: Paraoxonase-1 (PON1) and chemokine (C-C motif) ligand 2 (CCL2). PON1 is an enzyme bound to high-density lipoproteins. It breaks down lipid peroxides in lipoproteins and cells, participates in the protection conferred by HDL against different infectious agents, and is considered part of the innate immune system. With PON1 deficiency, CCL2 production increases, inducing migration and infiltration of immune cells in target tissues and disturbing normal metabolic function. This disruption involves pathways controlling cellular homeostasis as well as metabolically-driven chronic inflammatory states. Hence, an understanding of these relationships would help improve treatments and, as well, identify new therapeutic targets.
Search related documents:
Co phrase search for related documents- activator janus kinase signal transducer and adaptive immunity: 1
- activity increase and acute phase: 1, 2, 3, 4, 5, 6
- activity increase and acute phase response: 1
- activity increase and adaptive immunity: 1, 2
- acute phase and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
- acute phase response and adaptive immunity: 1
Co phrase search for related documents, hyperlinks ordered by date